IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
metoclopramide
metoclopramide
Brand names:
Reglan
Form
Strength
SOLUTION, INJECTABLE
5 mg/mL
SYRUP, ORAL
5 mg/5 mL
TABLET, ORAL
5 mg
Display
Prokinetic Agents
Class:
563200
Medication comments:
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
Renal Dosing Program
View all
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
metoclopramide
IV/PO
(
Reglan
©
)
Refer to
or other reference.
No distinction between IV/PO or indication
CrCl > 60: No adjustment necessary
CrCl 11-59: Administer 50% of usual total daily dose.
CrCl <11,HD/PD: Administer 33% or less of total daily dose.
Last updated:
May. 24, 2021
Black Box Warnings
Tardive Dyskinesia
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
• Indications
Comments
(Reglan©)
No distinction between IV/PO or indication
CrCl 11-59: Administer 50% of usual total daily dose.
CrCl <11,HD/PD: Administer 33% or less of total daily dose.